NYMOX PHARMACEUTICAL CORPORATION Total Assets
NYMOX PHARMACEUTICAL CORPORATION (NYMXF) had Total Assets of $654.00 thousand as of 2024-12-31, per its 20-F filed 2025-06-03.
Financial Statements › Notes
ifrs-full:Assets · last filed 2025-06-03
- 2024-12-31: Assets $654.00K.
- 2024-09-30: Assets $624.00K.
- 2023-12-31: Assets $627.00K.
- 2023-09-30: Assets $669.00K.
| Period end | Assets |
|---|---|
| 2024-12-31 | $654.00K 20-F · filed 2025-06-03 |
| 2024-09-30 | $624.00K 6-K · filed 2025-01-02 |
| 2023-12-31 | $627.00K 20-F · filed 2025-06-03 |
| 2023-09-30 | $669.00K 6-K · filed 2023-11-15 |
| 2023-06-30 | $271.00K 6-K · filed 2023-08-14 |
| 2023-03-31 | $575.00K 6-K · filed 2023-05-12 |
| 2022-12-31 | $1.63M 20-F · filed 2024-08-29 |
| 2022-09-30 | $3.14M 6-K/A · filed 2022-11-16 |
| 2022-06-30 | $4.47M 6-K · filed 2022-08-15 |
| 2022-03-31 | $1.24M 6-K · filed 2022-05-13 |
| 2021-12-31 | $1.44M 20-F · filed 2023-05-02 |
| 2021-09-30 | $3.85M 6-K · filed 2021-11-12 |
| 2021-06-30 | $6.67M 6-K · filed 2021-08-13 |
| 2021-03-31 | $1.46M 6-K · filed 2021-05-14 |
| 2020-12-31 | $4.34M 20-F · filed 2022-03-30 |
| 2020-09-30 | $5.74M 6-K · filed 2020-11-13 |
| 2020-06-30 | $1.05M 6-K · filed 2020-08-14 |
| 2020-03-31 | $3.37M 6-K · filed 2020-05-14 |
| 2019-12-31 | $5.49M 20-F · filed 2022-03-30 |
| 2019-09-30 | $7.46M 6-K · filed 2019-11-13 |
| 2019-06-30 | $9.52M 6-K · filed 2019-08-14 |
| 2019-03-31 | $11.80M 6-K · filed 2019-05-15 |
| 2018-12-31 | $8.08M 20-F · filed 2021-03-29 |
| 2018-09-30 | $4.78M 6-K · filed 2018-11-13 |
| 2018-06-30 | $5.17M 6-K · filed 2018-08-13 |
| 2018-03-31 | $954.00K 6-K · filed 2018-05-15 |
| 2017-12-31 | $979.00K 20-F · filed 2020-03-30 |
| 2016-12-31 | $2.06M 20-F · filed 2019-03-29 |
| 2015-12-31 | $712.00K 20-F · filed 2018-03-30 |